Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 6, 2011

Premium

CombiMatrix has appointed Jeff Hayes as director of sales for the oncology market. Before joining the Irvine, Calif.-based molecular diagnostics firm, Hayes held marketing management positions with Schering-Plough and Eli Lilly, as well as sales management roles with US Labs and Plus Diagnostics.

Hayes will head the sales effort for CombiMatrix's DNAarray test portfolio, which includes its DNAarray Heme Profile for hematologic malignancies, DNAarray Tumor Profile for various solid tumors, and DNAarray Breast Profile.

Separately, CombiMatrix said last week that Daniel Forche plans to resign from his position as senior vice president of sales and marketing in order to pursue other opportunities. Forche joined the company in October 2010 from Agendia, where he held the position of vice president of sales and marketing.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.